Editorial: Mitochondrial damage interacts with the immune system and tumor microenvironment
Open Access
- 30 June 2025
- journal article
- editorial
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1646413
Abstract
Despite the clinical success of immunotherapy in certain cancers, patient sensitivity and resistance remain persistent challenges. As the primary energy powerhouses of eukaryotic cells, mitochondria exhibit dysfunction and metabolic perturbations that alter endogenous molecular expression (1,2). Mitochondria also extensively participate in emerging cell death processes such as ferroptosis and cuproptosis, consequently reshaping the infiltration and functional state of tumor immune cells. Exploring mitochondria-associated targets and their crosstalk with cell death pathways represents a potential approach to overcome immunotherapy resistance.Keywords
This publication has 8 references indexed in Scilit:
- Mitochondria and cell deathNature Cell Biology, 2024
- Mitophagy curtails cytosolic mtDNA-dependent activation of cGAS/STING inflammation during agingNature Communications, 2024
- Targeting Erbin-mitochondria axis in platelets/megakaryocytes promotes B cell-mediated antitumor immunityCell Metabolism, 2024
- Copper homeostasis and cuproptosis in mitochondriaLife Sciences, 2023
- Role of mitochondrial alterations in human cancer progression and cancer immunityJournal of Biomedical Science, 2023
- Raddeanin A Enhances Mitochondrial DNA‐cGAS/STING Axis‐Mediated Antitumor Immunity by Targeting Transactive Responsive DNA‐Binding Protein 43Advanced Science, 2023
- Top 10 Challenges in Cancer ImmunotherapyImmunity, 2020
- Mitochondria are the powerhouses of immunityNature Immunology, 2017